InflaRx Reports Full Year 2024 Results and Highlights Key Achievements and Expected Milestones
Received European Commission approval for GOHIBIC® (vilobelimab) for the treatment of SARS-CoV-2-induced acute respiratory distress syndrome ...
Mum begs doctors to amputate as UTI turns out to be something far more sinister
Mum Teresa Jones, 59, was diagnosed with Pyoderma Gangrenosum - a rare skin condition that causes large, painful ulcers to ...
Chunks of mum’s leg cut fell OFF after a ‘bug bite’ turned out to be flesh-rotting disease
A MUM begged doctors to amputate her leg after ‘bug bites’ turned out to be a flesh-rotting disease. Teresa Jones told how ...
'I had a UTI and ended up begging doctors to cut my leg off'
The 59-year-old was left housebound for a year due to the agonising pain and she had to watch as nurses cut away chunks of ...
Best Biotech Stocks To Watch Now – March 12th
AbbVie, CervoMed, Thermo Fisher Scientific, Danaher, Vertex Pharmaceuticals, Cencora, and Cognizant Technology Solutions are the seven Biotech stocks to watch today, according to MarketBeat’s stock ...
Biotech Stocks To Add to Your Watchlist – March 11th
AbbVie, Danaher, and Thermo Fisher Scientific are the three Biotech stocks to watch today, according to MarketBeat’s stock ...
Terrifying and painful new skin disease ravages young father, with doctors warning it will kill him
A 39-year-old father is suffering from a horrifically painful skin disease that doctors can't cure or even definitively ...
InflaRx Showcases Vilobelimab’s Role in Immuno-Dermatology at the 2025 AAD Annual Meeting
InflaRx N.V. (Nasdaq: IFRX), a biopharmaceutical company pioneering anti-inflammatory therapeutics targeting the complement system, today announced the presentation of multiple posters describing the ...
24/7 Wall St23d
Market Correction Wake-Up Call? 4 Dependable High-Yield Dividend Kings to the Rescue
Everything that could go wrong for a long and tired stock market rally came to the forefront in late February, and the same items that led to the worst month for the S&P 500 since 2022, could ...